Long-term treatment with olsalazine for ulcerative colitis: safety and relapse prevention: a follow-up study.
In a published placebo-controlled study comprising 101 patients, olsalazine was shown to possess relapse-preventing properties superior to placebo and similar to those of sulphasalazine. This is a retrospective follow-up of the 76 patients who continued olsalazine treatment on an open basis. The relapse pattern is similar to that of patients on sulphasalazine treatment, and the long-term tolerance and safety are encouraging.
Sandberg-Gertzén
H
H
Department of Medicine, Orebro Medical Centre Hospital, Sweden.
Järnerot
G
G
Tysk
C
C
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors
D000636:Aminosalicylic Acids; C032587:olsalazine